These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 2521734

  • 1. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.
    Taylor A, Ziffer JA, Steves A, Eshima D, Delaney VB, Welchel JD.
    Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734
    [Abstract] [Full Text] [Related]

  • 2. The kidney: imaging with Tc-99m mercaptoacetyltriglycine, a technetium-labeled analog of iodohippurate.
    Russell CD, Thorstad BL, Stutzman ME, Yester MV, Fowler D, Dubovsky EV.
    Radiology; 1989 Aug; 172(2):427-30. PubMed ID: 2526350
    [Abstract] [Full Text] [Related]

  • 3. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
    Coveney JR, Robbins MS.
    J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of Tc-99m mercaptoacetyltriglycine in patients with impaired renal function.
    Taylor A, Eshima D, Christian PE, Milton W.
    Radiology; 1987 Feb; 162(2):365-70. PubMed ID: 2948212
    [Abstract] [Full Text] [Related]

  • 5. Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders.
    Jafri RA, Britton KE, Nimmon CC, Solanki K, Al-Nahhas A, Bomanji J, Fettich J, Hawkins LA.
    J Nucl Med; 1988 Feb; 29(2):147-58. PubMed ID: 2964516
    [Abstract] [Full Text] [Related]

  • 6. 99mTc-MAEC complexes: new renal radiopharmaceuticals combining characteristics of (99m)Tc-MAG3 and (99m)Tc-EC.
    Taylor AT, Lipowska M, Hansen L, Malveaux E, Marzilli LG.
    J Nucl Med; 2004 May; 45(5):885-91. PubMed ID: 15136640
    [Abstract] [Full Text] [Related]

  • 7. Technetium-99m-N,N-ethylenedicysteine--a comparative study of renal scintigraphy with technetium-99m-MAG3 and iodine-131-OIH in patients with obstructive renal disease.
    Ozker K, Onsel C, Kabasakal L, Sayman HB, Uslu I, Bozluolçay S, Cansiz T, Kapicioğlu T, Urgancioğlu I.
    J Nucl Med; 1994 May; 35(5):840-5. PubMed ID: 8176468
    [Abstract] [Full Text] [Related]

  • 8. Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers.
    Taylor A, Eshima D, Fritzberg AR, Christian PE, Kasina S.
    J Nucl Med; 1986 Jun; 27(6):795-803. PubMed ID: 2940350
    [Abstract] [Full Text] [Related]

  • 9. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
    Kabasakal L, Turoğlu HT, Onsel C, Ozker K, Uslu I, Atay S, Cansiz T, Sönmezoğlu K, Altiok E, Isitman AT.
    J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
    [Abstract] [Full Text] [Related]

  • 10. A comparative study of renal scintigraphy and clearance with technetium-99m-MAG3 and iodine-123-hippurate in patients with renal disorders.
    Müller-Suur R, Bois-Svensson I, Mesko L.
    J Nucl Med; 1990 Nov; 31(11):1811-7. PubMed ID: 2146371
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of altered physiologic states on clearance and biodistribution of technetium-99m MAG3, iodine-131 OIH, and iodine-125 iothalamate.
    Taylor A, Eshima D.
    J Nucl Med; 1988 May; 29(5):669-75. PubMed ID: 2967354
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. 99mTc-MAG3 versus 131I-orthoiodohippurate in the routine determination of effective renal plasma flow.
    Bagni B, Portaluppi F, Montanari L, Prandini N, Zatta G.
    J Nucl Med Allied Sci; 1990 May; 34(2):67-70. PubMed ID: 2147211
    [Abstract] [Full Text] [Related]

  • 16. Renal and extrarenal clearance of 99mTc-MAG3: a comparison with 125I-OIH and 51Cr-EDTA in patients representing all levels of glomerular filtration rate.
    Rehling M, Nielsen BV, Pedersen EB, Nielsen LE, Hansen HE, Bacher T.
    Eur J Nucl Med; 1995 Dec; 22(12):1379-84. PubMed ID: 8586082
    [Abstract] [Full Text] [Related]

  • 17. 99mTc-MAG3, a new renal imaging agent: preliminary results in patients.
    Taylor A, Eshima D, Alazraki N.
    Eur J Nucl Med; 1987 Dec; 12(10):510-4. PubMed ID: 2952506
    [Abstract] [Full Text] [Related]

  • 18. Comparison of 99Tcm-mercaptoacetyltriglycine and 131I-orthoiodohippurate in determination of effective renal plasma flow (ERPF).
    Abdel-Dayem HM, Sadek S, al-Bahar R, Sabha M, el-Sayed M.
    Nucl Med Commun; 1989 Feb; 10(2):99-107. PubMed ID: 2525236
    [Abstract] [Full Text] [Related]

  • 19. [Advantages of the new radiopharmaceutic agent, 99mTC-mercaptoacetyltriglycine (99mTc-MAG3), in the diagnosis of kidneydiseases. A comparative study with 131I-OIH, 99mTc-DTPA and 99mTc-DMSA].
    Lepej J, Marosová A, Kliment J, Buchanec J, Svitác J, Klisenbauer L.
    Bratisl Lek Listy; 1992 May; 93(5):258-65. PubMed ID: 1327424
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.